Treatment of difficulty in breathing with Unani medicine Habb-e-Sadr
- Conditions
- Health Condition 1: J459- Other and unspecified asthma
- Registration Number
- CTRI/2024/06/069434
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Males and females of 18-65 years.
2. Patients of Bronchial Asthma for at least 3 months presenting with at least one of the following symptoms:
Wheeze
Shortness of breath
Chest tightness and cough that vary over time
and in intensity,
Expiratory airflow limitation as suggested by a
decreased FEV1
3. Objective evidence for reversible airway obstruction (=12% and =200 mL change in FEV1 and/or a 25% and 60 L/min change in PEFR) either spontaneously or after treatment.
4. Patients with Asthma Control Questionnaire Score more than 1.5
1. FEV1/FVC ratio less than 50%.
2. Pregnant and lactating mother
3. Patient with other Respiratory Tract Infections, tuberculosis and malignancy.
4. Patient of Presence of chronic cough with expectoration for 2-3 months in each of 2 successive years.
5. Patient with co-morbidities, Diabetes Mellitus, Hepatic and Renal Insufficiency.
6. Patients with Tobacco Smoking.
7. Patient with regular use of oral or systemic corticosteroids for conditions other than Asthma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of the study drug in the treatment of mild to moderate Zeeq un Nafas (Bronchial Asthma) will be assessed on the basis of Absolute Eosinophil Count (AEC), IgE, Spirometory test, FeNO test and improvement in the Asthma Control Questionnaire (ACQ).Timepoint: At baseline and 2, 4, 6 weeks
- Secondary Outcome Measures
Name Time Method Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and 6 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.